Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Clinical Oncology|September 5, 2003
Target molecules in specific immunotherapy against prostate cancerMamoru Harada, Masanori Noguchi, Kyogo Itoh
Cancer Science|July 5, 2003
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patientsKazuhiko Kobayashi, Masanori Noguchi, Kyogo Itoh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
The Prostate|September 2, 2003
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patientsMamoru Harada, Kazuhiko Kobayashi, Satoko Matsueda, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancerSatoko Matsueda, Kazuhiko Kobayashi, Yoichi Nonaka, et al.
Oncology Reports|August 4, 2004
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patientsMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
The Prostate|July 21, 2004
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+ prostate cancer patientsRika Ogata, Satoko Matsueda, Akihisa Yao, et al.
Oncology Reports|July 6, 2007
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancerShigenori Homma, Yoshihiro Komohara, Mamoru Harada, et al.
The Prostate|June 4, 2004
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patientsSatoko Matsueda, Akihisa Yao, Yuki Ishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Akihisa Yao, et al.
Pageof 29